deferoxamine has been researched along with Anemia, Iron-Deficiency in 19 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Anemia, Iron-Deficiency: Anemia characterized by decreased or absent iron stores, low serum iron concentration, low transferrin saturation, and low hemoglobin concentration or hematocrit value. The erythrocytes are hypochromic and microcytic and the iron binding capacity is increased.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Further, there is lack of agreement about the benefits of deferoxamine (Dfx) in the treatment of anemia and oxidative stress during inflammation and chronic diseases." | 3.69 | Iron metabolism and oxidative stress during acute and chronic phases of experimental inflammation: effect of iron-dextran and deferoxamine. ( Mitjavila, MT; Muntané, J; Puig-Parellada, P, 1995) |
| "Background Thrombocytopenia is common in sick neonates." | 1.46 | Eltrombopag, a thrombopoietin mimetic, crosses the blood-brain barrier and impairs iron-dependent hippocampal neuron dendrite development. ( Bastian, TW; Chen, MJ; Connor, JR; Duck, KA; Georgieff, MK; Lanier, LM; Liu, ZJ; Michalopoulos, GC; Sola-Visner, MC, 2017) |
| "Iron deficiency and visceral leishmaniasis are serious problems of public health." | 1.37 | Leishmania chagasi: effect of the iron deficiency on the infection in BALB/c mice. ( Malafaia, G; Marcon, Lde N; Pedrosa, ML; Pereira, Lde F; Rezende, SA, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Pietra, V | 1 |
| Degrassi, S | 1 |
| Fusi-Schmidhauser, T | 1 |
| Zhdanov, VV | 1 |
| Udut, EV | 1 |
| Sotnikova, LS | 1 |
| Burmina, YV | 1 |
| Miroshnichenko, LA | 1 |
| Simanina, EV | 1 |
| Polyakova, TY | 1 |
| Zyuz'kov, GN | 1 |
| Chaikovskii, AV | 1 |
| Stavrova, LA | 1 |
| Fedorova, EP | 1 |
| Dygai, AM | 1 |
| Usende, IL | 1 |
| Leitner, DF | 1 |
| Neely, E | 1 |
| Connor, JR | 2 |
| Olopade, JO | 1 |
| Bastian, TW | 1 |
| Duck, KA | 1 |
| Michalopoulos, GC | 1 |
| Chen, MJ | 1 |
| Liu, ZJ | 1 |
| Lanier, LM | 1 |
| Sola-Visner, MC | 1 |
| Georgieff, MK | 1 |
| Lakhal, S | 1 |
| Talbot, NP | 1 |
| Crosby, A | 1 |
| Stoepker, C | 1 |
| Townsend, AR | 1 |
| Robbins, PA | 1 |
| Pugh, CW | 1 |
| Ratcliffe, PJ | 1 |
| Mole, DR | 1 |
| Malafaia, G | 1 |
| Marcon, Lde N | 1 |
| Pereira, Lde F | 1 |
| Pedrosa, ML | 1 |
| Rezende, SA | 1 |
| Zhao, GY | 1 |
| Zhao, LP | 1 |
| He, YF | 1 |
| Li, GF | 1 |
| Gao, C | 1 |
| Li, K | 1 |
| Xu, YJ | 1 |
| Kuvibidila, SR | 2 |
| Porretta, C | 1 |
| De, BK | 1 |
| Roberts, WL | 1 |
| Fidler, MC | 1 |
| Davidsson, L | 1 |
| Walczyk, T | 1 |
| Hurrell, RF | 1 |
| RICHMOND, J | 1 |
| FIELDING, J | 1 |
| Wood, DM | 1 |
| Thomson, AH | 1 |
| Lawes, M | 1 |
| Jones, AL | 1 |
| Dargan, PI | 1 |
| Nurtjahja-Tjendraputra, E | 1 |
| Fu, D | 1 |
| Phang, JM | 1 |
| Richardson, DR | 1 |
| Muntané, J | 1 |
| Puig-Parellada, P | 1 |
| Mitjavila, MT | 1 |
| Reynolds, T | 1 |
| Mirfattahi, M | 1 |
| Lomas, G | 1 |
| Sajedianfard, J | 1 |
| Boroujeni, HM | 1 |
| Habibzadeh, F | 1 |
| Kitchens, D | 1 |
| Baliga, BS | 1 |
| Huang, JY | 1 |
| Wu, MS | 1 |
| Wu, CH | 1 |
2 trials available for deferoxamine and Anemia, Iron-Deficiency
| Article | Year |
|---|---|
Regulation of growth differentiation factor 15 expression by intracellular iron.
Topics: Adenocarcinoma; Anemia, Iron-Deficiency; Basic Helix-Loop-Helix Transcription Factors; Breast Neopla | 2009 |
Iron absorption from fish sauce and soy sauce fortified with sodium iron EDTA.
Topics: Adult; Anemia, Iron-Deficiency; Biological Availability; Deferoxamine; Diet; Edetic Acid; Female; Fe | 2003 |
17 other studies available for deferoxamine and Anemia, Iron-Deficiency
| Article | Year |
|---|---|
The Dark Side of Iron.
Topics: Acidosis; Adolescent; Anemia, Iron-Deficiency; Deferoxamine; Drug Overdose; Female; Ferrous Compound | 2020 |
Pathogenetic Evaluation of Dysfunction in the Erythron System of Experimental Animals during Modeling of Iron Deficiency Anemia in the Gestation Period.
Topics: Anemia, Iron-Deficiency; Animals; Blood Cell Count; Bone Marrow; Deferoxamine; Erythrocytes; Erythro | 2016 |
The Deterioration Seen in Myelin Related Morphophysiology in Vanadium Exposed Rats is Partially Protected by Concurrent Iron Deficiency.
Topics: Anemia, Iron-Deficiency; Animals; Animals, Newborn; Astrocytes; Cells, Cultured; Deferoxamine; Femal | 2016 |
Eltrombopag, a thrombopoietin mimetic, crosses the blood-brain barrier and impairs iron-dependent hippocampal neuron dendrite development.
Topics: Anemia, Iron-Deficiency; Animals; Benzoates; Biological Transport; Biomimetics; Blood-Brain Barrier; | 2017 |
Leishmania chagasi: effect of the iron deficiency on the infection in BALB/c mice.
Topics: Anemia, Iron-Deficiency; Animals; Cytokines; Deferoxamine; Female; Hemoglobins; Leishmania infantum; | 2011 |
A comparison of the biological activities of human osteoblast hFOB1.19 between iron excess and iron deficiency.
Topics: Alkaline Phosphatase; Anemia, Iron-Deficiency; Apoptosis; Calcification, Physiologic; Cell Line; Cel | 2012 |
Differential effects of iron deficiency on the expression of CD80 and CD86 co-stimulatory receptors in mitogen-treated and untreated murine spleen cells.
Topics: Anemia, Iron-Deficiency; Animals; Antigens, CD; B7-1 Antigen; B7-2 Antigen; Biomarkers; Cell Divisio | 2002 |
Performance characteristics of the Dimension RxL iron and total iron-binding capacity methods.
Topics: Anemia, Iron-Deficiency; Deferoxamine; Drug Overdose; Hemoglobins; Humans; Iron; Iron Chelating Agen | 2003 |
IRON DEFICIENCY ANAEMIA.
Topics: Anemia; Anemia, Hypochromic; Anemia, Iron-Deficiency; Deferoxamine; Drug Therapy; Hematologic Diseas | 1964 |
DIFFERENTIAL FERRIOXAMINE TEST FOR MEASURING CHELATABLE BODY IRON.
Topics: Anemia; Anemia, Aplastic; Anemia, Hemolytic; Anemia, Iron-Deficiency; Anemia, Pernicious; Deferoxami | 1965 |
Hepatocellular damage following therapeutic intravenous iron sucrose infusion in a child.
Topics: Anemia, Iron-Deficiency; Chemical and Drug Induced Liver Injury; Child, Preschool; Deferoxamine; Fer | 2005 |
Iron chelation regulates cyclin D1 expression via the proteasome: a link to iron deficiency-mediated growth suppression.
Topics: Anemia, Iron-Deficiency; Animals; Cell Cycle; Cell Line, Tumor; Deferoxamine; G1 Phase; Half-Life; H | 2007 |
Iron metabolism and oxidative stress during acute and chronic phases of experimental inflammation: effect of iron-dextran and deferoxamine.
Topics: Acute Disease; Anemia, Iron-Deficiency; Animals; Carrageenan; Chronic Disease; Deferoxamine; Disease | 1995 |
Desferrioxamine infusion due to heparin interference with iron assay. A paediatric problem.
Topics: Adolescent; Anemia, Iron-Deficiency; Blood Specimen Collection; Child, Preschool; Deferoxamine; Fail | 1997 |
Therapeutic values of different routes of administration of vitamin A with ferrous sulfate in treating deferoxamin-induced iron-deficiency anemia.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Animals; Deferoxamine; Ferrous Compounds; Injections, | 1999 |
In vivo and in vitro iron deficiency reduces protein kinase C activity and translocation in murine splenic and purified T cells.
Topics: Anemia, Iron-Deficiency; Animals; Body Weight; CD3 Complex; Cell Division; Cell Membrane; Cells, Cul | 1999 |
The effect of an iron supplement on serum aluminum level and desferrioxamine mobilization test in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Aluminum; Anemia, Iron-Deficiency; Deferoxamine; Female; Ferritins; | 2001 |